Actuate Therapeutics, Inc. Common stock Made Big Gain
Mon, Jul 13, 2026 at 07:33 PM
Actuate Therapeutics, Inc. Common stock (ACTU:NASDAQ) shot up at $1.5, representing a gain of 24%. On Mon, Jul 13, 2026, ACTU:NASDAQ hit a New 2-Week Intraday High of $1.6. From Mon, Jun 29, 2026, the stock recorded 33.33% Up Days and 30.00% Green Days
About Actuate Therapeutics, Inc. Common stock (ACTU:NASDAQ)
Actuate Therapeutics is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen...
Top 10 Gainers:
- Twin Vee Powercats Co. (VEEE:NASDAQ), 415.77%
- Hempacco Co., Inc. (HPCO:NASDAQ), 100%
- Q32 Bio Inc. (QTTB:NASDAQ), 90.72%
- Agenus Inc. (AGEN:NASDAQ), 82.69%
- Mint Incorporation Limited (MIMI:NASDAQ), 37.67%
- Brera Holdings PLC (SLMT:NASDAQ), 35.58%
- Eshallgo Inc. (EHGO:NASDAQ), 29.27%
- Sky Quarry Inc. (SKYQ:NASDAQ), 25.47%
- SRx Health Solutions Inc. (SRXH:NYSEMKT), 24.55%
- Actuate Therapeutics, Inc. Common stock (ACTU:NASDAQ), 23.97%